Intro

This chapter examines a retrospective cohort study on lab testing frequency among rheumatology patients, revealing a low adherence rate to recommended monitoring schedules. It advocates for personalized testing approaches rather than uniform standards, highlighting that many lab abnormalities may not be clinically relevant.